CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 592,650 shares (option exercise)
- 4 Open-market buy Director bought 2,285,342 shares at an average $0.64 ($1,463,487)
- 4 Open-market sale Interim CFO, Prin Acct Off sold 1,323 shares at $0.62 ($818)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Former Chief Medical Officer sold 3,769 shares at $0.69 ($2,608)
- 4 Open-market sale Principal Accounting Officer sold 3,316 shares at $0.60 ($1,980)
- 4 Open-market sale Chief Medical Officer sold 14,380 shares at $0.60 ($8,588)
- 4 Open-market sale Principal Accounting Officer sold 1,655 shares at $0.99 ($1,641)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 15 · 287 filings